Phil manages intellectual property (IP) rights across all technologies within TIAP’s (previously MaRS Innovation) portfolio. He advises on various forms of IP protection, assessing patentability and managing patent application filings and prosecution decisions. Phil also manages projects in TIAP’s Life Sciences portfolio. He performs technical and market due diligence on new technologies to support and expand TIAP’s portfolio. In addition, he develops business, technical, and strategic plans and engages with industry partners in order to support new start-up ventures.

Prior to joining TIAP, Phil trained with an intellectual property boutique law firm in downtown Toronto as a member of the firm’s life sciences patent practice group, where he was exposed to a wide array of technologies including biologics, small molecules, medical devices, and information technologies. He has also acted as director of intellectual property for a biotechnology start-up company in Mississauga that specializes in developing antibody-based products for use in animal health and food safety.

Phil holds a PhD in Molecular Genetics from the University of Toronto and a JD from Osgoode Hall Law School.